Natural Products Lysobactin and Sorangicin A Show
            <i>In Vitro</i>
            Activity against Mycobacterium abscessus Complex

Sullivan, Jaryd R.; Yao, Jacqueline; Courtine, Christophe; Lupien, Andréanne; Herrmann, Jennifer; Müller, Rolf; Behr, Marcel A.

doi:10.1128/spectrum.02672-22

Microbiol Spectr

2022

DOI: 10.1128/spectrum.02672-22

|View full text |Cite

Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex

Jaryd R. Sullivan

Jacqueline Yao

Christophe Courtine

et al.

Abstract: The many thousands of people living with cystic fibrosis are at a greater risk of developing a chronic lung infection caused by Mycobacterium abscessus . Since M. abscessus is clinically resistant to most anti-TB drugs available, treatment options are limited to macrolides.

Help me understand this report

View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products

Amruta Adhikrao,

Mayuri Motiram,

Kumar

2024

CTMC

View full text Add to dashboard Cite

Nontuberculous Mycobacteria (NTM) refer to bacteria other than all Mycobacterium species that do not cause tuberculosis or leprosy, excluding the species of the Mycobacterium tu-berculosis complex, M. leprae and M. lepromatosis. NTM are ubiquitous and present in soils and natural waters. NTM can survive in a wide range of environmental conditions. The direct inocu-lum of the NTM from water or other materials is most likely a source of infections. NTMs are re-sponsible for several illnesses, including pulmonary alveolar proteinosis, cystic fibrosis, bronchi-ectasis, chronic obstructive pneumoconiosis, and pulmonary disease. Recent reports suggest that NTM species have become insensitive to sterilizing agents, antiseptics, and disinfectants. The ef-ficacy of existing anti-NTM regimens is diminishing and has been compromised due to drug re-sistance. New and recurring cases of multidrug-resistant NTM strains are increasing. Thus, there is an urgent need for ant-NTM regimens with novel modes of action. This review sheds light on the mode of antimicrobial resistance in the NTM species. Then, we discussed the repurposable drugs (antibiotics) that have shown new indications (activity against NTM strains) that could be developed for treating NTM infections. Also, we have summarised recently identified natural leads acting against NTM, which have the potential for treating NTM-associated infections.

show abstract

Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products

Amruta Adhikrao,

Mayuri Motiram,

Kumar

2024

CTMC

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex

Abstract: The many thousands of people living with cystic fibrosis are at a greater risk of developing a chronic lung infection caused by Mycobacterium abscessus . Since M. abscessus is clinically resistant to most anti-TB drugs available, treatment options are limited to macrolides.

Cited by 1 publication

References 50 publications

Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products

Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products

Contact Info

Product

Resources

About